Because younger women diagnosed with breast cancer and those with a family history of breast and/or ovarian cancer are at higher risk of carrying a BRCA1/2 gene mutation, diagnostic DNA testing is offered to this subset of breast cancer patients [2]. The gene discussed is BRCA1; the disease is ovarian carcinoma.